Discovery of highly potent α-keto ester-based peptidomimetic inhibitors of the Hip1 protease for the treatment of <i>Mycobacterium tuberculosis</i>.

Schumann N, Shamma F, Brooks CL, Johnson SJ, Yim MK, Olsen KJ, Peña K, Karakousis PC, Abell A, Goldfarb NE.

Open source

DOI
10.1016/j.ejmcr.2025.100311
Published
2025-11-15
Container
Eur J Med Chem Rep
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1016/j.ejmcr.2025.100311,
  title = {Discovery of highly potent α-keto ester-based peptidomimetic inhibitors of the Hip1 protease for the treatment of \<i\>Mycobacterium tuberculosis\</i\>.},
  author = {Schumann N and  Shamma F and  Brooks CL and  Johnson SJ and  Yim MK and  Olsen KJ and  Peña K and  Karakousis PC and  Abell A and  Goldfarb NE.},
  year = {2025},
  journal = {Eur J Med Chem Rep},
  doi = {10.1016/j.ejmcr.2025.100311},
  url = {https://doi.org/10.1016/j.ejmcr.2025.100311}
}

RIS

TY  - JOUR
TI  - Discovery of highly potent α-keto ester-based peptidomimetic inhibitors of the Hip1 protease for the treatment of <i>Mycobacterium tuberculosis</i>.
AU  - Schumann N
AU  -  Shamma F
AU  -  Brooks CL
AU  -  Johnson SJ
AU  -  Yim MK
AU  -  Olsen KJ
AU  -  Peña K
AU  -  Karakousis PC
AU  -  Abell A
AU  -  Goldfarb NE.
PY  - 2025
JO  - Eur J Med Chem Rep
DO  - 10.1016/j.ejmcr.2025.100311
UR  - https://doi.org/10.1016/j.ejmcr.2025.100311
ER  - 

APA

N, S., F, S., CL, B., SJ, J., MK, Y., KJ, O., K, P., PC, K., A, A., & NE., G. (2025). Discovery of highly potent α-keto ester-based peptidomimetic inhibitors of the Hip1 protease for the treatment of <i>Mycobacterium tuberculosis</i>.. Eur J Med Chem Rep. https://doi.org/10.1016/j.ejmcr.2025.100311

Source records